The U.S. Food and Drug Administration approved medicaldevice maker Olympus’ redesigned duodenoscope.
The agency said the changes aim to lower the risk of infections through contamination. In February, Olympus will begin recalling its TJF-Q180V model duodenoscope from an estimated 4,400 healthcare facilities. Scopes made by Olympus and other manufacturers have been linked to 25 infection incidents between 2012 and 2015 in the U.S., where as many as 250 patients acquired antibioticresistant infections, according to a Senate committee minority staff report released last week. Modifications to Olympus’ scope aim to prevent leaking believed to increase infection risk.